Talk:Apalutamide

This is the talk page for discussing improvements to the Apalutamide article.
This is not a forum for general discussion of the article's subject.

Put new text under old text. Click here to start a new topic.
New to Wikipedia? Welcome! Learn to edit; get help.

Article policies

Find medical sources: Source guidelines · PubMed · Cochrane · DOAJ · Gale · OpenMD · ScienceDirect · Springer · Trip · Wiley · TWL

Ideal sources for Wikipedia's health content are defined in the guideline Wikipedia:Identifying reliable sources (medicine) and are typically review articles. Here are links to possibly useful sources of information about Apalutamide.

PubMed provides review articles from the past five years (limit to free review articles)
The TRIP database provides clinical publications about evidence-based medicine.
Other potential sources include: Centre for Reviews and Dissemination and CDC

Pharmacology Mid‑importance

	This article is within the scope of WikiProject Pharmacology, a collaborative effort to improve the coverage of Pharmacology on Wikipedia. If you would like to participate, please visit the project page, where you can join the discussion and see a list of open tasks.PharmacologyWikipedia:WikiProject PharmacologyTemplate:WikiProject Pharmacologypharmacology articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Chemicals Low‑importance

	This article is within the scope of WikiProject Chemicals, a daughter project of WikiProject Chemistry, which aims to improve Wikipedia's coverage of chemicals. To participate, help improve this article or visit the project page for details on the project.ChemicalsWikipedia:WikiProject ChemicalsTemplate:WikiProject Chemicalschemicals articles
Low	This article has been rated as Low-importance on the project's importance scale.

Medicine Mid‑importance

	Medicine portal This article is within the scope of WikiProject Medicine, which recommends that medicine-related articles follow the Manual of Style for medicine-related articles and that biomedical information in any article use high-quality medical sources. Please visit the project page for details or ask questions at Wikipedia talk:WikiProject Medicine.MedicineWikipedia:WikiProject MedicineTemplate:WikiProject Medicinemedicine articles
Mid	This article has been rated as Mid-importance on the project's importance scale.

Could use a section on clinical trials

A section on clinical trials could note significant phase II results, and any progress on the phase III trials. - Rod57 (talk) 18:19, 8 February 2017 (UTC)[reply]

interim analysis of phase III SPARTAN announced [1] "The median metastasis-free survival time was 40.5 months and 16.2 months in the apalutamide and placebo groups, respectively (hazard ratio, 0.28; 95% CI, 0.23–0.55; P < .001)." - awaiting publication ? - Rod57 (talk) 14:19, 12 February 2018 (UTC)[reply]

Formula

There is probably an error in the formula, as the benzene ring with cyano group should actually be a pyridine ring (as per IUPAC name). — Preceding unsigned comment added by Prohnily (talk • contribs) 07:40, 23 November 2017 (UTC)[reply]

Availability

The availability section is incorrect/outdated. The drug is also available in Europe: https://www.ema.europa.eu/en/medicines/human/EPAR/erleada 2A02:8106:258:3A00:6D5E:5C26:9A38:3B6 (talk) 10:11, 26 June 2020 (UTC)[reply]

Talk:Apalutamide

Could use a section on clinical trials

Formula

Availability

Navigation menu

Search